4//SEC Filing
Baeuerle Patrick 4
Accession 0000899243-20-033475
CIK 0001750019other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 6:16 AM ET
Size
6.4 KB
Accession
0000899243-20-033475
Insider Transaction Report
Form 4
Baeuerle Patrick
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-12-10+12,100→ 12,100 totalExercise: $31.83Exp: 2030-12-09→ Common Stock (12,100 underlying)
Holdings
- 350,786(indirect: By APAK Solutions GmbH)
Common Stock
Footnotes (2)
- [F1]The reported securities are owned directly by APAK Solutions GmbH. The Reporting Person is managing director of APAK Solutions GmbH. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
- [F2]25% of this option shall vest and become exercisable on January 1, 2022, with the remainder vesting in twenty-four (24) equal monthly installments thereafter.
Documents
Issuer
TCR2 THERAPEUTICS INC.
CIK 0001750019
Entity typeother
Related Parties
1- filerCIK 0001362054
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 6:16 AM ET
- Size
- 6.4 KB